As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.
9 Analysts have issued a Celsion Corporation forecast:
9 Analysts have issued a Celsion Corporation forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -16 -16 |
20%
20%
|
|
| EBIT (Operating Income) EBIT | -16 -16 |
19%
19%
|
|
| Net Profit | -16 -16 |
13%
13%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Celsion Corp . is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
| Head office | United States |
| CEO | Stacy Lindborg |
| Employees | 25 |
| Founded | 1982 |
| Website | imunon.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


